APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 177 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $152,160 | -58.2% | 4,000 | 0.0% | 0.00% | -60.0% |
| Q2 2023 | $364,400 | +38.1% | 4,000 | 0.0% | 0.01% | +42.9% |
| Q1 2023 | $263,840 | +13.2% | 4,000 | -11.1% | 0.01% | +16.7% |
| Q4 2022 | $233,000 | -24.1% | 4,500 | 0.0% | 0.01% | -33.3% |
| Q3 2022 | $307,000 | -24.6% | 4,500 | -50.0% | 0.01% | -10.0% |
| Q2 2022 | $407,000 | -10.9% | 9,000 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $457,000 | +7.3% | 9,000 | 0.0% | 0.01% | +25.0% |
| Q4 2021 | $426,000 | +43.4% | 9,000 | 0.0% | 0.01% | +33.3% |
| Q3 2021 | $297,000 | -47.8% | 9,000 | 0.0% | 0.01% | -53.8% |
| Q2 2021 | $569,000 | -96.6% | 9,000 | -97.7% | 0.01% | -96.4% |
| Q1 2021 | $16,554,000 | +9524.4% | 385,795 | +12759.8% | 0.36% | +9025.0% |
| Q4 2020 | $172,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |